Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World’s Smallest Intradermal Delivery Device
NanoPass Technologies Secures Awz Ventures' $4M Investment, Signaling Growth and Innovation in Intradermal Delivery Technology
InvestmentManagement Changes
ננופס תחל בניסוי במוצר שעשוי לשפר את יעילות חיסוני הקורונה
InvestmentPartners
NanoPass's intradermal injection platform proven to sustain COVID-19 vaccine antibodies using 1/15 of the dose reports Chinese Institute of Medical Biology
Partners
ננו-פאס פיתחה את המחט הרפואית הזעירה בעולם - Techtime - חדשות אלקטרוניקה והייטק
Partners
West Makes Investment in NanoPass Technologies
Investment
NanoPass Technologies to Supply MicronJet600™ Device to Immune Design for Use in ZVex-based Oncology Immunotherapy Products
Partners
NanoPass Technologies Grants an Exclusive License to Circassia Pharmaceuticals, for use of its MicronJet600™ Device in Allergy Testing in the US
Partners
NanoPass Technologies Grants a Commercial License to Janssen Pharmaceuticals, Inc., for use of its MicronJet Device
Partners
Skin delivery solutions co NanoPass raises several million dollars
Investment
The Biologics News and Reports Portal
Partners
https://www.idri.org/idri-use-nanopass-micorneedle-technology/
Hate Needles? Now NanoPass needles offer painless vaccinations...
Customers
Intradermal drug delivery co NanoPass raises $6.5m
Investment